Our Sarcoma Care Team

Our expert staff coordinates treatment, as well as all necessary follow-up and rehabilitation, using a team approach. Individually tailored treatment plans increase survival rates and improve a patient’s quality of life.

Medical Oncology

Medical Oncologist

Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.

Director of Women's Cancers, Lifespan Cancer Institute, Clinical Director, Gynecologic Medical Oncology and Director of Medical Oncology, Rhode Island Hospital

Don S. Dizon, MD, FACP, FASCO, is an oncologist who specializes in women's cancers. He is the director of women's cancers at Lifespan Cancer Institute and director of medical oncology at Rhode Island Hospital. He is also a professor of medicine at The Warren Alpert Medical School of Brown University. His research interests are in novel treatments of women’s cancers and issues related to survivorship, particularly as they relate to sexual health after cancer for both men and women.

He is a prolific researcher and writer, and he has authored hundreds of publications, including peer-reviewed articles, books and book chapters. He is an active member of the American Society of Clinical Oncology, SWOG cancer research network, and the National Consortium of Breast Cancers, of which he has served as both vice president and president. 

Pediatric Oncology

Pediatric Hematology/Oncology

Roma Bhuta, DO, is a pediatrician who specializes in hematology/oncology at Hasbro Children’s Hospital. She is an assistant professor at The Warren Alpert Medical School of Brown University. Dr. Bhuta is a member of the Children’s Oncology Group, the American Society of Pediatric Hematology/Oncology, the Consortium for New England Childhood Cancer Survivors and the Dana Farber Acute Lymphoblastic Leukemia Consortium.

Pediatric Hematology/Oncology

Bradley DeNardo, MD, is a board-certified pediatrician who specializes in pediatric hematology and oncology at Hasbro Children’s Hospital. He is an assistant professor of pediatrics at The Warren Alpert Medical School of Brown University. After attending The Warren Alpert Medical School, Dr. DeNardo continued dedicating his time to the medical students there by instructing them in pediatrics for the following nine years. In addition, Dr. DeNardo is a consulting physician at Women and Infants Hospital.

Dr. DeNardo’s work has been published in several peer-reviewed journals and books, and he has also presented his research at the local, regional and international levels. He is a member of a number of professional societies, including Children’s Oncology Group and the American Society of Pediatric Hematology/Oncology.

Director, Pediatric Hematology/Oncology

Rishi R. Lulla, MD, MS, is the chief of pediatric hematology/oncology at Hasbro Children’s Hospital and an international expert in the care of children and young adults with brain and spinal cord tumors. After completing his residency and fellowship at Northwestern University in Chicago, Dr. Lulla spent several years as an attending physician on the pediatric neuro-oncology team at Northwestern. He has recently been given the Hero Award for outstanding dedication to pediatric neuro-oncology by the Pediatric Brain Tumor Foundation, and was named one of Chicago’s Top Cancer Doctors by Chicago magazine.

Dr. Lulla’s scientific work has been published in more than 20 peer-reviewed journals and two books. He has presented his findings on pediatric central nervous system tumors at the local, national, and international levels, and he has served as principal investigator to multiple grant-sponsored research investigations. His current research activities are focused on translating laboratory findings into novel treatment for children with brain and spinal cord tumors. He served as the executive chair of the Children’s Brain Tumor Tissue Consortium and is an active member of the American Society of Pediatric Hematology Oncology, the Children’s Oncology Group, and the Society of Neuro-Oncology.

Surgical Oncology

Chief of Surgical Oncology, Rhode Island Hospital

Thomas Miner, MD, is chief of surgical oncology at Rhode Island Hospital. He is an associate professor of surgery at The Warren Alpert Medical School of Brown University and an expert in gastric cancer surgery.

Dr. Miner's research interests include the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for cancers with diffuse involvement of the abdominal cavity.

Chief of Musculoskeletal Oncology, Rhode Island Hospital

Richard Terek, MD is an orthopedic surgeon and musculoskeletal oncologist who specializes in reconstructive surgery and musculoskeletal oncology for adult and pediatric patients. He is an expert in the treatment of patients with bone and soft tissue tumors. He is actively engaged in medical education and is an NIH-funded investigator whose research is focused on understanding how bone cancer grows and spreads to other parts of the body, with the ultimate goal of developing new targeted therapies. He is professor in the department of orthopedic surgery at The Warren Alpert Medical School of Brown University.

Dr. Terek received his medical degree from the University of Chicago Pritzker School of Medicine in Chicago. He completed his orthopedic surgery residency at Loyola University Medical Center in Maywood, Illinois, and was an American Cancer Society Clinical Oncology Fellow in surgical oncology at Memorial Sloan-Kettering Cancer Center in New York, New York.

Dr. Terek is certified by the American Board of Orthopedic Surgery and is a fellow of the American Academy of Orthopedic Surgeons and the American College of Surgeons. He is past president of the Rhode Island Orthopedic Society and president-elect of the Musculoskeletal Tumor Society.

Learn more about the Orthopedics Institute »

Pediatric Surgery

Pediatric Surgeon

Arlet G. Kurkchubasche, MD, is a board-certified general and pediatric surgeon who has provided care at Hasbro Children's Hospital for the past 20 years. She is currently the program director for the Pediatric Surgery Fellowship Program at The Warren Alpert Medical School of Brown University, one of 40 such programs in North America.

In addition to her clinical training, she spent time in the labs at Children's Hospital of Pittsburgh, where she also developed her passion for management of patients with complicated health issues and intestinal failure, and this remains her clinical focus to date. She currently remains active in multiple clinical trials, especially those examining the outcomes of infants after surgical interventions. She has also spearheaded a pediatric program in thyroid cancer that provides more age-appropriate care to this population of children. Her focus on pediatric tumors has been evidenced by her position as the regional surgical co-principal investigator for the Children's Oncology Group and as the chair of the pediatric tumor board.

She remains active in all aspects of pediatric surgery (abdominal and thoracic, open and minimally invasive), airway endoscopy, and neonatal patent ductus arteriosus (PDA) ligations.

Pediatric Surgeon-in-Chief and Division Chief of Pediatric Surgery, Hasbro Children's Hospital

Francois Luks, MD, PhD, is pediatric surgeon-in-chief and division chief of pediatric surgery at Hasbro Children’s Hospital. 

Dr. Luks earned his bachelor’s degree from Rijksuniversitair Centrum Antwerpen, his medical degree from Universitaire Instelling Antwerpen, and his PhD in medical sciences from Catholic University Leuven, all in his native Belgium. He completed his residency in general surgery at Catholic Medical Center of Brooklyn and Queens (NY), then a residency in pediatric surgery at Hospital Ste-Justine in Montreal. He spent two years on a research fellowship through Catholic University of Leuven before joining both Hasbro and Women & Infants as Attending Surgeon in 1994. 

Dr. Luks has taken on progressively senior management roles at Hasbro, serving as director for trauma in the PICU for 15 years from 1995 to 2010, then subsequently director of trauma for the whole of Hasbro Children’s Hospital. He has served on and led more than a dozen standing and ad hoc committees at the hospital, from those in his specialty like the Pediatric Trauma Patient Care Committee, which he chaired, to those addressing issues in the broader hospital community, such as the Rhode Island Hospital Strategic Planning Committee. He has also continued to serve concurrently as attending surgeon at Women & Infants, and for several years each as attending surgeon at Morton Hospital (Taunton, MA) and New England Medical Center (Boston, MA). He also operates at St. Anne's Hospital in Fall River, MA. 

His research interests include fetal development and fetal surgery, and in particular the etiology of twin-to-twin transfusion syndrome. He was the site principal investigator for the first randomized study on endoscopic fetal surgery for this syndrome; the Brown Fetal Treatment Program was the only North American center participating in the study. The program is a founding member of the North American Fetal Treatment Network (NAFTNet); Dr. Luks has been a member of its Executive Committee since 2007.

Dr. Luks has published and presented widely, with more than 120 peer-reviewed publications and book chapters and more than 100 abstracts. He has served The Warren Alpert Medical School of Brown University for his entire 25 years in Providence, currently as director of the Program in Fetal Medicine, and professor of surgery, pediatrics and obstetrics & gynecology. Throughout the course of his time at Brown he has served as independent course director, faculty sponsor and thesis director to numerous promising medical students.

Pediatric Trauma Medical Director, Adolescent Bariatric Surgeon

Elizabeth J. Renaud, MD, is a surgeon at Rhode Island and The Miriam hospitals. She specializes in pediatric surgery and performs procedures at Hasbro Children’s Hospital. At Albany Medical Center, she was a pediatric trauma program director, associate professor of surgery and associate surgical residency program director. She held similar leadership positions at the University of Massachusetts Memorial Medical Center between 2009 and 2011. She was honored with the New York Rising Stars award in 2013.

Dr. Renaud’s research interests include trauma, outcomes research, minimally invasive surgery, and adolescent bariatric surgery. Her work has been published in several peer-reviewed journals and book chapters, such as the Journal of Pediatric Surgery and the Journal of Trauma and Acute Care Surgery. She has presented her research on topics such as endometrial cancer, appendicitis and childhood obesity. She is a member of the American Society for Metabolic and Bariatric Surgery, the Pediatric Trauma Society and the American Pediatric Surgical Association.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board-certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, Massachusetts, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity-modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Radiation Oncologist

Esther Yu, MD, is a radiation oncologist at Rhode Island Hospital. A 2012 graduate of Emory University School of Medicine, Dr. Yu has published her research on breast, central nervous system, and gastrointestinal cancers in many medical journals, and has presented at several national meetings for radiation oncology. She was named chief resident during her final year of residency at Tufts Medical Center in 2016-2017.

Dr. Yu is a winner of the American Brachytherapy Society’s 2016 HDR Scholarship Award. She holds a number of professional memberships including the American Society for Radiation Oncology and the American College of Radiation Oncology.